Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
Ellingson, Benjamin M., Kim, Hyun J., Woodworth, Davis C., Pope, Whitney B., Cloughesy, Jonathan N., Harris, Robert J., Lai, Albert, Nghiemphu, Phioanh L., Cloughesy, Timothy F.Volume:
271
Language:
english
Journal:
Radiology
DOI:
10.1148/radiol.13131305
Date:
April, 2014
File:
PDF, 2.29 MB
english, 2014